Analyst Ratings for Scribe Therapeutics Inc (SCTX)

SCTX Rating Summary

SCTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on SCTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $49.00 (+80.7%) * Over Last 12-Mos
Rating Score: 7.5 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/18/2026 Leerink David Risinger New Coverage Outperform
(N/A)
37.00
(N/A)
21.19
(27.11)
27.94% Details
8/18/2026 Wells Fargo N/A New Coverage Overweight
(N/A)
60.00
(N/A)
20.73
(27.11)
30.78% Details